US buys HIV drug for low-income nations

The U.S. will purchase 2 million doses of a new twice-yearly HIV prevention drug for low-income countries. The purchase, under the PEPFAR program, aims to protect up to 2 million people by 2028, with distribution plans to be developed with recipient governments. This initiative addresses concerns about access to the drug lenacapavir following previous cuts to foreign aid.